Beta-blockers in hypertension: adding insult to injury.
Kaplan
Norman M
NM
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000009:adverse effects*; D002318:Cardiovascular Diseases / Q000209:etiology* / Q000401:mortality / Q000517:prevention & control; D002986:Clinical Trials as Topic; D005060:Europe; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D018570:Risk Assessment; D012955:Societies, Medical; D013548:Sweden; D017211:Treatment Failure; D006113:United Kingdom
D000319:Adrenergic beta-Antagonists